1-1049033-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_198576.4(AGRN):​c.4272G>A​(p.Ala1424Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000722 in 1,571,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., cov: 25)
Exomes 𝑓: 0.00072 ( 0 hom. )

Consequence

AGRN
NM_198576.4 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.00

Publications

0 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-1049033-G-A is Benign according to our data. Variant chr1-1049033-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 474130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.4272G>A p.Ala1424Ala synonymous_variant Exon 24 of 36 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.4272G>A p.Ala1424Ala synonymous_variant Exon 24 of 36 1 NM_198576.4 ENSP00000368678.2 O00468-6

Frequencies

GnomAD3 genomes
AF:
0.000703
AC:
106
AN:
150746
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.000319
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00185
Gnomad ASJ
AF:
0.00145
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000842
Gnomad OTH
AF:
0.00145
GnomAD2 exomes
AF:
0.000446
AC:
79
AN:
177082
AF XY:
0.000384
show subpopulations
Gnomad AFR exome
AF:
0.000514
Gnomad AMR exome
AF:
0.0000712
Gnomad ASJ exome
AF:
0.00162
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000742
Gnomad OTH exome
AF:
0.000839
GnomAD4 exome
AF:
0.000724
AC:
1028
AN:
1420304
Hom.:
0
Cov.:
51
AF XY:
0.000680
AC XY:
478
AN XY:
703048
show subpopulations
African (AFR)
AF:
0.000215
AC:
7
AN:
32564
American (AMR)
AF:
0.000177
AC:
7
AN:
39438
Ashkenazi Jewish (ASJ)
AF:
0.00122
AC:
31
AN:
25420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37616
South Asian (SAS)
AF:
0.0000124
AC:
1
AN:
80918
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48818
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4098
European-Non Finnish (NFE)
AF:
0.000861
AC:
941
AN:
1092714
Other (OTH)
AF:
0.000698
AC:
41
AN:
58718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
60
121
181
242
302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000703
AC:
106
AN:
150852
Hom.:
0
Cov.:
25
AF XY:
0.000611
AC XY:
45
AN XY:
73672
show subpopulations
African (AFR)
AF:
0.000318
AC:
13
AN:
40920
American (AMR)
AF:
0.00185
AC:
28
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
5
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5102
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4736
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10460
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000842
AC:
57
AN:
67716
Other (OTH)
AF:
0.00144
AC:
3
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000764
Hom.:
0
Bravo
AF:
0.00106

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AGRN: BP4, BP7 -

Nov 04, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

AGRN-related disorder Benign:1
Nov 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Congenital myasthenic syndrome 8 Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.28
DANN
Benign
0.72
PhyloP100
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201470321; hg19: chr1-984413; API